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ABSTRACT 
Seven different plants from Nigerian herbs were investigated for anti-
infective properties. The plant crude extracts, obtained by maceration 
with methanol, were subjected to array of antimicrobial screening 
tests. Antimycobacterial susceptibility of M. tuberculosis (H37Rv 
strain) was performed by Alamar Blue Assay.  The results showed 
Spondias mombin and Anacardium occidentale to have 68 and 63% 
inhibition respectively against P. aeruginosa (ATCC 27853). The 
secondary test on the S. mombin extract against P. aeruginosa had 
IC50 of 37.32μg/ml. Two EtOAC-MeOH soluble fractions of 
exhibited good antimicrobial activities. One fraction (AOF9) 
exhibited antifungal activity against Candida glabrata with IC50 
value of 9.0µg/ml while the other fraction (AOF8) showed 
antibacterial activity against Pseudomonas aeruginosa with IC50 
value of 28.3µg/ml. The result of the antimycobacterial screening 
tests proved Spondias mombin most potent for providing 
antiturbercular compounds and was further investigated by HPLC-
based activity profiling. The HPLC fractions revealed SM8-9, SM14 
and SM15 to be effective (94.9, 98.3 and 92.8% Inhibitions 
respectively) against M. tuberculosis H37RV as compared with 
reference drugs. The findings show Spondias mombin and 
Anacardium occidentale to possess good anti-infective potentials and 
these support the folkloric uses of the plants for the treatment of 
infectious diseases. 
Keywords: Anti-infective, antimicrobial screening, 
antimycobacterial, antitubercular, Spondias mombin, Anacardium 
occidentale. 
INTRODUCTION 
A key factor in the discovery of new 
drugs is not only on the layman information 
collected from traditional medicine but 
much also on the rigorous investigation of 
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the plant extracts for various biological 
activities regardless of their uses or folkloric 
claims and of their activity in traditional 
medicine1. We are faced with ever-
increasing health threats from "notorious" 
and opportunistic infections, multidrug 
resistant pathogens and cancers. Diseases 
such as tuberculosis, gonorrhea, malaria, and 
childhood ear infections are now more 
difficult to treat than they were decades 
ago2.     
In order to combat these important 
health challenges, discovery of new 
medicinal agents with novel modes of 
activity is imperative. Screening for new 
natural products through an ethnobotanical 
approach is an effective method of drug 
discovery that focuses on medicinal plants 
used by indigenous peoples3. Higher plants 
can provide compounds with new structural 
features and novel mechanisms of biological 
activity. As prototype medicinal agents, they 
may provide starting points for synthetic or 
semisynthetic modifications aimed at 
enhancing their potency or therapeutic 
potential4,5. Therefore, the present study was 
carried out to determine the anti-infective 
properties of some plants commonly used as 
herbal helps in South-West Nigeria. The 
selected plant materials were screened for 
antibacterial, antifungal, and 
antimycobacterial properties via activity-
guided assays.  
 
MATERIALS AND METHODS 
Plant Materials 
The plant samples were collected at 
various locations in Ibadan, Nigeria in 
February 2008; and identified by Dr. O. A. 
Ugbogu of Forestry Research Institute of 
Nigeria (FRIN), Ibadan. Voucher specimens 
(Table 1) were deposited in the herbarium.  
 
Preparation of extracts  
The oven-dried (450C) plant samples 
were powdered and macerated with methanol 
at room temperature. Extracts were strained 
and filtered over anhydrous sodium sulphate 
and then evaporated in vacuo at 450C. The 
concentrated extracts (yields: Table1) were 
kept in refrigerator for antimicrobial tests. 
Only the very active crude extracts were 
subjected to fractionation by vacuum liquid 
chromatography (VLC) and HPLC 
successively.  
 
VLC and HPLC conditions 
Spondias mombin and Anacardium 
occidentale extracts was fractionated by VLC 
and evaluated for antimicrobial activity in 
cell-based assays. The VLC analysis was run 
on Si gel 230-400 mesh (Merck) with 
gradient elution in normal phase. The portion 
of S. mombin which exhibited significant 
antimycobacterial property was further 
investigated by HPLC-based activity 
profiling. Reversed-phase HPLC was 
performed on a waters Prep LC system 400 
(column: Luna C8 21.2 x 250 mm, flow rate 
15ml/min; detector wavelength, 254nm) 
 
Microorganisms and inoculums 
All organisms were obtained from the 
American Type Culture Collection 
(Manassas, VA. USA). The following 
pathogens were used for antimicrobial study: 
Mycobaterium tuberculosis (H37Rv), C. 
albicans (ATCC 90028), C. neoformans 
(ATCC 90113), C. glabrata (ATCC 90030), 
A. fumigatus (ATCC 90906), MRSA (ATCC 
43300), E. coli (ATCC 35218), P. aeruginosa 
(ATCC 27853), and M. intracellulare (ATCC 
23068). 
 
Preliminary bioactivity screening of plant 
samples 
 The crude methanol extracts of the 
selected plants were subjected to general 
preliminary bioactivity screening. The 
antimicrobial evaluation was conducted 
against the following pathogens: 
Mycobaterium tuberculosis (Mtb), C. 
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albicans (ATCC 90028), C. glabrata (ATCC 
90030), C. neoformans (ATCC 90113), A. 
fumigatus (ATCC 90906), MRSA (ATCC 
43300), E. coli (ATCC 35218), P. aeruginosa 
(ATCC 27853), and M. intracellulare (ATCC 
23068).     
Susceptibility testing was performed 
using a modified version of the NCCLS 
methods6,7.  Mycobaterium intracellulare and 
A. fumigatus growth were monitored using 
Alamar BlueTM (BioSource International; 
Camarillo, CA, USA)6-8. Sample dissolved in 
DMSO were serially diluted using 20%/0.9% 
DMSO/saline and transferred in duplicate to 
96-well flat bottom microplates. Microbial 
inocula were prepared by diluting saline 
suspensions of colonies with assay broth to 
afford recommended colony forming 
units/ml. Growth (saline only), solvent and 
blank (media only) controls were included on 
each test plate. Drug controls [ciprofloxacin, 
ICN Biomedicals; Aurora, OH, USA) for 
bacteria and amphotericin B (ICN 
Biomedicals) for fungi] were included in each 
assay. All organisms were read at either 630 
nm using the EL-340 Biokinetics Reader(Bio-
Tek Instruments; Winooski, VT, USA) or 544 
ex/590 em, (M. intracellulare,  A. fumigatus) 
using the Polarstar Galaxy Plate Reader 
(BMG LabTechnologies; Offenberg, 
Germany) prior to and after incubation. The 
MIC (minimum inhibitory concentration) was 
defined as the lowest test concentration that 
allowed no detectable growth.  
 
Antimycobacterial assay 
A microplate-based assay which uses 
Alamar blue reagent for determination of 
growth was used. Percent inhibition of 
fraction agents against Mycobacterium 
tuberculosis H37Rv was determined in the 
microplate Alamar blue assay6-9. 
Antimicrobial susceptibility testing 
was performed in black, clear-bottomed, 96-
well microplates (black view plates; Packard 
Instrument Company, Meriden, Conn.) in 
order to minimize background fluorescence. 
Outer perimeter wells were filled with sterile 
water to prevent dehydration in experimental 
wells. Initial drug dilutions were prepared in 
either dimethyl sulfoxide or distilled 
deionized water, and subsequent twofold 
dilutions were performed in 0.1 ml of 7H9GC 
(no Tween 80) in the microplates. Inocula 
were initially diluted 1:2 in 7H9GC and 0.1 
ml was added to wells which resulted in 
bacterial titers of 1 x 106 CFU/ml in plate 
wells for H37Rv.Wells containing drug only 
were used to detect autofluorescence of 
compounds. Additional control wells 
consisted of bacteria only (B) and medium 
only (M). Plates were incubated at 37°C. 
Starting at day 4 of incubation, 20µl of 10 x 
alamar blue solution (Alamar 
Biosciences/Accumed, Westlake, Ohio) and 
12.5 µl of 20% Tween 80 were added to one 
B well and one M well, and plates were 
reincubated at 37°C. Wells were observed at 
12 and 24 h for a color change from blue to 
pink and for a reading of ≥50,000 
fluorescence units (FU). Fluorescence was 
measured in a Cytofluor II microplate 
fluorometer (PerSeptive Biosystems, 
Framingham, Mass.) in bottom-reading mode 
with excitation at 530 nm and emission at 590 
nm. If the B wells became pink by 24 h, 
reagent was added to the entire plate. If the 
well remained blue or ≤50,000 FU was 
measured, additional M and B wells were 
tested daily until a color change occurred, at 
which time reagents were added to all 
remaining wells. Plates were then incubated 
at 37°C, and results were recorded at 24 h 
post-reagent addition. 
Percent inhibition was defined as 1 - 
(test well FU/mean FU of triplicate B wells) x 
100. The lowest drug concentration effecting 
an inhibition of ≥ 90% was considered the 
MIC. 
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RESULTS & DISCUSSION 
The experimental approach engaged 
in the present study involved an initial 
primary screening of the crude extracts of 
selected plants (Table 1) against some 
pathogenic microorganisms. The results 
(Table 2) of the general biological screening 
of the selected plant samples showed 
Spondias mombin and Anacardium 
occidentale to have 68 and 63% inhibition 
respectively against P. aeruginosa ATCC 
27853. The secondary screening test on the 
methanol extract of S. mombin against P. 
aeruginosa revealed moderate activity with 
IC50 of 37.32μg/ml (Table 3). The EtOAC-
MeOH soluble fractions of A. occidentale 
exhibited antifungal activity (Table 4) against 
Candida glabrata with IC50 value of 9.0 
µg/ml (AOF9) and antibacterial activity 
against Pseudomonas aeruginosa with IC50 
value of 28.3µg/ml (AOF8). The remaining 
plants were inactive against array of 
pathogens: C. albicans ATCC 90028, C. 
neoformans ATCC 90113, C. glabrata ATCC 
90030, A. fumigatus ATCC 90906, MRSA 
ATCC 43300, E. coli ATCC 35218, P. 
aeruginosa ATCC 27853, and M. 
intracellulare ATCC 23068. In vitro activities 
of the screened plant extracts against 
Mycobacterium tuberculosis (Table 5) 
revealed moderate potency of Spondias 
mombin against Mycobacterium tuberculosis 
H37RV. The crude extract of the stem bark of 
Spondias mombin that demonstrated most 
promising antitubercular activity (27% 
inhibition) in the primary screening was 
subsequently fractionated using VLC and 
HPLC techniques respectively. Fractions VL2 
and VL3 (Table 6) showed good activities 
against Mtb (91% and 69% inhibition 
respectively) compared to other fractions. 
VL2 had MIC of 61.1μg/ml (Table 7) at a 
concentration of 64μg/ml. Subsequently, VL2 
and VL3 were pooled together to afford VLF 
which was later purified by HPLC. The 
fluorometric microplate alamar blue assay 
(MABA) of the HPLC fractions (Table 8) 
revealed SM8-9, SM14 and SM15 to be 
effective (94.9, 98.3 and 92.8% Inhibition 
respectively) against M. tuberculosis H37RV 
as compared with reference drugs. The 
chromatogram (Figure 1) of HPLC analysis 
of the VLC active portion of Spondias 
mombin portrayed the retention time areas of 
the anti-Mtb active column fractions of SM8-
9, SM14 and SM15.  
The use of the selected plants is 
popular in folkloric medicine for the 
treatment of infectious diseases10,11,  
Anacardium occidentale is used in traditional 
medicine for the treatment of diabetes 
mellitus. Water extract of the bark is used for 
the treatment of dysentery, fever, pains, 
amenorrhea and diarrhea10-12. Spondias 
mombin has been reported to have 
antibacterial, antifungal, and antiviral13-15. 
Phytochemical screening (Table 9) of the 
stem barks of both Spondias mombin and 
Anacardium occidentale revealed the 
presence of the following classes of natural 
products-tannins, phenols, flavonoids, 
saponins, saponins glycosides, cardenolides, 
anthraquinones and alkaloids (traces in S. 
mombin) while phlobatannins were found 
absent. An anti-Mtb active fraction of S. 
mombin (SM15) was positive for 
Liebermann-Burchard test of triterpenoids. 
Antimicrobial activities are some of 
the cited biological properties displayed by 
phenolics and triterpenoids4-16 and these 
classes of natural products are well 
accumulated in S. mombin and A. occidentale 
which may be responsible for the anti-
infective properties of the two plant agents. 
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Table 1. Selected plants for anti-infectives 
 
 
Table 2. Antimicrobial activities of the screened plant extracts - Primary assay % Growth 
inhibition 
 
Sample E. coli P. aerug MRS M. intracellulare C. neoformans C. albicans A. fumigatus 
S.  mombin     
stem bark 
39 68 0 0 0 1 5 
F. paniculata  
leaf 
11 0 0 0 0 0 0 
A. occidentalis 
stem bark 
51 63 26 4 0 35 7 
A. sativum   
bulb 
6 0 5 0 17 8 0 
A. montanus    
leaf 
19 5 0 0 23 7 2 
A . montanus  
root 
3 5 0 0 0 4 0 
S. campulata 
stem bark 
6 2 4 0 15 13 0 
1. Sample % Growth inhibition < 50 are considered inactive Assays run @50μg/ml 
 
 
 
S/n Species Parts FHI NO. % Yield 
1 Spondias mombin Stem bark 107896 5.1 
2 Flabellaria paniculata Leaf 106122 8.2 
3 Anacardium occidentale Stem bark 107898 16.6 
4 Allium sativum Bulb 107900 30.0 
5 Acanthus montanus Leaf 107897 3.6 
6 Acanthus montanus Root 107897 16.4 
7 Spathodea campulata Stem bark 107899 12.7 
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Table 3. Antimicrobial activities of MeOH extract of S. mombin - Secondary assay 
 
Sample/control drug E. coli P. aerug MRS M. intracellulare C. neoformans C.   albicans A. fumigatus 
S. mombin >50 37.32 - - - >50 - 
Amphotericin B - -- - - 0.55 0.25 0.70 
Ciprofloxacin 0.006 0.075 0.10 0.30 - - - 
IC 50 ≤ 20μg/ml was considered active   *The concentration (μg/ml) that affords 50% inhibition 
of growth 
 
       Table 4. Antimicrobial activities of the VLC fractions of Anacardium occidentale 
 
Sample/control drug C. glabrata S. aureus MRS         P. aeruginosa 
AOF6 >50 NA NA >50 
AOF7 28.7 NA NA 34.2 
AOF8 12.6 NA NA 28.3 
AOF9 9.0 NA NA 34.2 
AOFI0 26.8 NA NA 32.2 
Amphotericin B 0.71 - - - 
Ciprofloxacin - - - 0.08 
*The concentration (μg/ml) that affords 50% inhibition of growth 
   MRS= Methicillin-resitant S. aureus; NA= Not active 
 
Table 5. In vitro activities of the screened plant extracts against Mycobacterium tuberculosis 
 
S/n Sample/control drug Parts % Inhibition 
1 Spondias mombin Stem bark 27 
2 Flabellaria paniculata Leaf 14 
3 Anacardium occidentale Stem bark 19 
4 Allium sativum Bulb 13 
5 Acanthus montanus Leaf 18 
6 Acanthus montanus Root 20 
7 Spathodea campulata Stem bark 20 
 RMP  99 
 INH  94 
Assays run @ 64μg/ml INH= isoniazid, RMP= rifampicin 
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Table 6. Antimycobacterial activities of the VLC column fractions of MeOH extract of S. 
mombin 
 
S/n Sample % Inhibition 
1 VL1 2 
2 VL2 91 
3 VL3 69 
4 VL4 32 
5 VL5 26 
6 VL6 27 
7 VL7 27 
8 VL8 13 
9 VL9 24 
10 VL10 8 
11 VL11 22 
 
Drug control 
 
 
RMP 99 
 
INH 94 
           M.TB strains: H37RV, inhibition of ≥90% was considered active, Assays run @ 64 μg/ml 
           INH= isoniazid, RMP= rifampicin. 
 
 
Table 7. MIC Results of the active VL2 fraction of S. mombin stem bark against M. tuberculosis 
 
Sample % Inhibition MIC (ug/ml) 
VL2 91 61.1 
Drug 
control   
RMP 99 0.07 
INH 94 0.61 
PA824 - 0.42 
                     INH= isoniazid, RMP= rifampin, PA824= is an experimental anti-tuberculosis drug 
                      % Inhibition assays run @ 64 μg/ml 
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Table 8. Antimycobacterial activities of HPLC column fractions of VLF against M.  tuberculosis 
 
S/n Sample % Inhibition 
1 SM8-9 94.9 
2 SM10-11 87.4 
3 SM13 85.7 
4 SM14 98.3 
5 SM15 92.8 
6 SM16 55.7 
7 SM17 49.1 
8 SM18 46.2 
9 SM19-20 36.5 
10 SM21 23.5 
11 SM22 20.2 
12 SMJET 60.0 
 
Drug control 
 
13 RMP 99.7 
14 INH 91.4 
       M.TB strains: H37RV, INH= isoniazid, RMP= rifampin;  
        inhibition of ≥90% was considered active, Assays run @ 64μg/ml 
 
 
Table 9. Results of phytochemical screening of Spondia mombin stem bark and Anacardium 
occidentale 
 
Class of Natural Product S. mombin A. occidentale 
Tannins +++ +++ 
Phlobatannins -- -- 
Phenols +++ ++ 
Flavonoids +++ ++ 
Saponins +++ +++ 
Saponin glycosides +++ +++ 
Cardenolides +++ +++ 
Anthraquinones ++ +++ 
Alkaloids + ++ 
            Key: +++ = High, ++ = Moderate, + = Mild, -- = Absent 
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Figure.1. HPLC chromatogram of the anti-Mtb active column fractions (SM8-9, SM14 and SM15) of 
Spondias mombin. 
